Follow your curiosity

What discovery has been shared with you?

Start with one fact. Explore it, go deeper, then follow whichever branch catches your imagination.

Choose subjects for a surprise

Exploring any topic

Begin your discovery

Your next discovery is one click away.

Choose one or more subjects above, or leave Any Topic selected and let curiosity decide.

Chemistry

Michaelis-Menten Enzyme Kinetics and Inhibition

Quick fact

The Michaelis-Menten model was published in 1913 by Leonor Michaelis and Maud Menten. Maud Menten was a Canadian medical doctor and one of the first women to earn a medical degree from the University of Toronto.

Why this is interesting

Ever wonder why drinking alcohol feels like it hits a limit—no matter how much you drink, your liver processes it at a nearly constant rate? The answer lies in how enzymes work, and it's captured by the Michaelis-Menten equation.

Read the full explanation

Understanding Michaelis-Menten Enzyme Kinetics and Inhibition

Think of an enzyme as a busy worker in a factory. The worker can only process one item at a time, and each item takes a fixed amount of time. If you bring in a few items, the worker processes them quickly. But if you flood the factory with items, the worker reaches maximum speed—the assembly line is saturated. That maximum speed is called Vmax (maximum velocity). The substrate concentration at which the worker works at half-speed is called Km (Michaelis constant). Km tells you how much of a substrate is needed to keep the enzyme half-occupied. This relationship between substrate concentration and reaction rate is the core of Michaelis-Menten kinetics.

A deeper explanation

The mechanism involves two steps: an enzyme (E) binds a substrate (S) to form an enzyme-substrate complex (ES), which then breaks down into product (P) and free enzyme. The model assumes a steady state where the concentration of ES remains constant. The rate of product formation is v = (Vmax [S]) / (Km + [S]). Inhibition changes these parameters. Competitive inhibitors bind at the active site, competing with substrate; they raise the apparent Km (more substrate needed to reach half Vmax) but do not affect Vmax. Noncompetitive inhibitors bind elsewhere, reducing the enzyme's activity; they lower Vmax while Km stays the same. Understanding this helps explain how drugs like statins work (competitive inhibition of HMG-CoA reductase) or why poisons like cyanide inhibit cytochrome c oxidase (noncompetitive). The model is essential for designing enzyme assays, developing pharmaceuticals, and predicting metabolic fluxes.

Keep FACTREE close

Internet access is required. Updates arrive when you reopen or reload the app. You may need to sign in again in the installed app.